Anal Dysplasia Clinic MidWest is involved in various clinical trials. For more information and/or to participate in one of our studies, click on one of the links below or give us a call at 312-623-2625.
  • ANCHOR study
    This study compares topical or ablative treatment with active monitoring in preventing anal cancer in patients with human immunodeficiency virus (HIV) and high-grade squamous intraepithelial lesions (HSIL).
  • AMC-103
    This study the use of a therapeutic vaccine (VGX-3100) and electroporation in treating patients with human immunodeficiency virus (HIV)-positive high-grade anal lesions.